Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTL201 in MS Spasticity
NCT03005119Phase 2Unknown
- Sponsor
- PhytoTech Therapeutics
- Start
- Mar 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in multiple sclerosis (MS) comparing PTL201 with Placebo (2 arms). Primary endpoints: Incidence of study treatment-related adverse events at 10 weeks and Change in sNRS scores at 4 weeks. Status: unknown.
02
Drugs
PTL201
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT03005119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03005119.